Rights and permissions
About this article
Cite this article
DX 890 achieves expected effect in paediatric CF patients. Inpharma Wkly. 1427, 8 (2004). https://doi.org/10.2165/00128413-200414270-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414270-00016